Exam 3 Lapinsky Summary

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/90

encourage image

There's no tags or description

Looks like no tags are added yet.

91 Terms

1
New cards

Vancomycin MOA

Binds D-Ala-D-Ala, inhibiting bacterial cell wall synthesis

2
New cards

Vancomycin primary coverage/clinical uses

Gram-positive organisms, including MRSA; only for C. difficile

3
New cards

Vancomycin must-know adverse effects

Nephrotoxicity; infusion reaction

4
New cards

Bactrim (TMP-SMX) MOA

Sequential inhibition of folate synthesis: SMX -> DHPS; TMP -> DFHR

5
New cards

Bactrim (TMP-SMX) primary coverage/clinical uses

UTIs, susceptible community MRSA, Pneumocytosis jirovcii

6
New cards

Bactrim (TMP-SMX) must-know adverse effects

Hyperkalemia, bone marrow suppression, SJS/TEN

7
New cards

Fluoroquinolones MOA

Inhibit DNA gyrase (Topoisomerase II) and topoisomerase IV

8
New cards

Fluoroquinolones Primary coverage/clinical uses

Gram-negative infections; selected respiratory infections

9
New cards

Fluoroquinolones must-known adverse effects

Tendiopathy/rupture, peripheral neuropathy, CNS effects, QT prolongation

10
New cards

Aminoglycosides MOA

Irreversible bind 30S ribosome; cause mRNA misleading

11
New cards

Aminoglycosides primary coverage/clinical uses

Serious aerobic Gram-negative infections; synergistic use in selected infections

12
New cards

Aminoglycoside must-known adverse effects

Nephrotoxicity, ototoxicity, neuromuscular blockade

13
New cards

Tetracyclines MOA

Reversibly bind 30S ribosomes; block aminoacyl-tRNA binding

14
New cards

Tetracyclines Primary coverage/clinical uses

Atypicals, tick-borne infections, acne, susceptible MRSA

15
New cards

Tetraycycline must-know adverse effects

Photosensitivity, esophagitis, tooth discoloration

16
New cards

Macrolide MOA

Bind 50S ribosome; inhibit translocation

17
New cards

Macrolide primary coverage/clinical use

Respiratory infections, atypical pathogens pertussis

18
New cards

Macrolide must-know adverse effects

GI effects, QT prolongation, drug interactions

19
New cards

Linezolid MOA

Binds 50S ribosome; prevents initiation complex formation

20
New cards

Linezolid primary coverage/clinical uses

MRSA, VRE, resistant Gram-positive infections

21
New cards

Linzeolid must know adverse effects

Thrombocytopenia, serotonin syndrome, neuropathy

22
New cards

Clindamycin MOA

Binds 50S ribosome; inhibits protein synthesis

23
New cards

Clindamycin primary coverage/clinical uses

Anaerobes (especially above diaphragm), selected Gram-positive infections

24
New cards

Clindamycin must-known adverse effects

C. difficile infection, diarrhea

25
New cards

Vancomycin high-yield molecular/pharmaceutical property

Large, polar glycopeptide; poorly absorbed orally

26
New cards

Vancomycin clinical consequence

IV for system infections; oral for intestinal C. difficile

27
New cards

Bactrim High-yield molecular/pharmaceutical property

Two drugs inhibit consecutive steps in folate synthesis

28
New cards

Bactrim clinical consequence

Synergistic antibacterial action; TMP causes hyperkalemia through renal ENaC inhibition

29
New cards

Fluoroquinolones high-yield molecular/pharmaceutical property

Chelate polyvalent metal cations

30
New cards

Fluoroquinolone clinical consequence

Oral absorption decreases with calcium, magnesium, aluminum, iron

31
New cards

Aminoglycoside high-yield molecular pharmaceutical property

Highly polar, polycationic molecules

32
New cards

Aminoglycoside clinical consequence

Poor oral absorption; poor CNS penetration renal elimination

33
New cards

Tetracycline high-yield molecular/pharmaceutical property

Chelate polyvalent metal cations

34
New cards

Tetracycline clinical consequence

Absorption reduced by antacids, iron, and certain dairy products

35
New cards

Macrolide high-yield molecular/pharmaceutical property

Weak bases that accumulate intracellularly

36
New cards

Macrolide clinical consequence

Useful against intracellular pathogens; erythromycin and clarithromycin inhibit CYP3A4

37
New cards

Linezolid high-yield molecular/pharmacueitcal property

Also inhibts monoamine oxidase (MAO), reversibly

38
New cards

Linezolid clinical consequence

Risk of serotonin syndrome with serotonergic drugs

39
New cards

Clindamycin high-yield molecular/pharmaceutical property

Strong activity against susceptible anaerobic gut flora

40
New cards

Clindamycin clinical consequence

Disrupts intestinal microbiota -> increased C. difficile risk

41
New cards

What drug class is Ciprofloxacin in?

Fluoroquinolones

42
New cards

What is a distinguishing clinical pearl regarding Ciprofloxacin

Strong gram-negative activity, including Pseudomonas; weak pneumococcal coverage

43
New cards

What drug class is Levofloxacin

Fluoroquinolones

44
New cards

What is a distinguishing clinical pearl regarding levofloxacin

Respiratory fluoroquinolone; covers S. pneumoniae and Pseudomonas

45
New cards

What drug class is moxifloxacin

Fluoroquinolones

46
New cards

What is a distinguishing clinical pearl regarding Moxifloxacin

Respiratory and anaerobic activity; not appropriate for UTIs because urinary concentrations are inadequate

47
New cards

What drug class is Ofloxacin

Fluoroquinolones

48
New cards

Distinguishing clinical pearl of Ofloxacin

Older fluoroquinolone; systemic, ophthalmic, and otic formulations

49
New cards

What drug class is Gentamicin

Aminoglycoside

50
New cards

Distinguishing clinical learn of Gentamicin

Serious gram-negative infections; selected synergistic regimens

51
New cards

What drug class is Tobramycin

Aminoglycoside

52
New cards

Distinguishing clinical pearl of Tobramycin

Particularly useful against Pseudomonas; inhaled formulation for chronic pulmonary infection

53
New cards

What drug class is Amikacin

Aminoglycosides

54
New cards

Distinguishing clinical pearl regarding Amikacin

Aminoglycoside

55
New cards

Distinguishing clinical pearl of Amikacin

Often retains activity against some gentamicin/tobramycin-resistant organisms

56
New cards

What drug class is Tetracycline

Tetracyclines

57
New cards

Distinguishing clinical pearl regarding Tetraycycline

Greater food/cation absorption concerns; renal elimination

58
New cards

What drug class is doxycycline

Tetracycline

59
New cards

Distinguishing clinical pearl regarding doxycycline

Excellent oral bioavailability; minimal dependence on renal clearance

60
New cards

What drug class is Minocycline

Tetracycline

61
New cards

Distinguishing clinical pearl of Minocycline

More lipophilic, vestibular adverse effects and pigmentation

62
New cards

What drug class is Azithromycin

Macrolide

63
New cards

Distinguishing clinical pearl regarding azithromycin

Long tissue persistence; relatively few CYP450 interactions

64
New cards

What drug class is Clarithromycin

Macrolide

65
New cards

Distinguishing clinical pearl regarding Clarithromycin

Strong CYP3A4 inhibitor; active metabolite

66
New cards

What drug class is Erythromycin

Macrolide

67
New cards

Distinguishing clinical pearl regarding Erythromycin

Strong CYP3A4 inhibitor; pronounced GI effects from motilin receptor stimulation

68
New cards

What antibiotic might a patient be taking if they develop tendon pain, and why?

Fluoroquinolones-tendon toxicity, potentially rupture

69
New cards

What antibiotic might a patient be taking if they develop hearing loss and why?

Aminoglycosides-Can cause ototoxicity

70
New cards

What antibiotic might a patient be taking if they develop hyperkalemia and why?

Bactrim-Trimethoprim blocks renal ENaC

71
New cards

What antibiotic might a patient be taking if they develop severe diarrhea/CDAD and why?

Clindamycin-Disruption of normal intestinal microbiota

72
New cards

What antibiotic might a patient be taking if they develop serotonin toxicity while also taking an SSRI and why?

Linezolid-Reversible MAO inhibition

73
New cards

What antibiotic might a patient be taking if they develop a decreased antibiotic absorption with iron supplements and why?

Tetracyclines or fluoroquinolones-Metal-ion chelation

74
New cards

What antibiotic might a patient be taking if they develop photosensitivity and why?

Tetracyclines or fluoroquinolones-Drug-associated phototoxicity

75
New cards

What antibiotic might a patient be taking if the antibiotic produces infusion-related flushing and why?

IV Vancomycin-Rate-dependent histamine release

76
New cards

What antibiotic might a patient be taking if they are also taking a statin and develop interaction concerns and why?

Clarithromycin, Erythromycin-CYP3A4 inhibition (Especially with CYP3A4-substrate statins)

77
New cards

What antibiotic might a patient be taking if the oral antibiotic treats intestinal infection but not systemic infection and why?

Vancomycin-Negligible oral bioavailability

78
New cards

Is Vancomycin primarily bactericidal or bacteriostatic

Primarily bactericidal

79
New cards

Is Bactrim primarily bactericidal or bacteriostatic

Primarily bactericidal

80
New cards

Are fluoroquinolones primarily bactericidal or bacteriostatic

Primarily bactericidal

81
New cards

Are amonglycosides primarily bactericidal or bacteriostatic

Primarily bactericidal

82
New cards

Are tetracyclines primarily bactericidal or bacteriostatic

Primarily bacteriostatic

83
New cards

Are Macrolides primarily bactericidal or bacteriostatic

Primarily bacteriostatic

84
New cards

Are Macrolides primarily bactericidal or bacteriostatic

Primarily bacteriostatic

85
New cards

Is Linezolid primarily bactericidal or bacteriostatic

Primarily bacteriostatic

86
New cards

is clindamycin primarily bactericidal or bacteriostatic

Primarily bacteriostatic

87
New cards

Take home message for Cell wall versus DNA versus ribosomes

Know the molecular target first

88
New cards

Take home message for 30S versus 50S

Aminoglycosides and tetracyclines target 30S; macrolides, linezolid and clindamycin target 50S

89
New cards

Take home message for molecular properties dictate PK

Vancomycin and aminoglycosides are poorly absorbed orally; tetracyclines and fluoroquinolones chelate cations

90
New cards

Take home message for mechanisms that explain patient care

TMP causes hyperkalemia; linezolid inhibits MAO; macrolides can inhibit CYP3A4

91
New cards

Take home message to recognize signature toxicities

Aminoglycosides -> Ears/kidneys

Fluoroquinolones -> tendons

Clindamycin -> C. Difficile

Linezolid -> Platelets